BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38211479)

  • 1. Schistosoma mansoni co-infection modulates Chagas disease development but does not impair the effect of benznidazole-based chemotherapy.
    Lozano KJG; Gonçalves Santos E; Vilas Boas DF; Oliveira RRG; Diniz LF; Benedetti MD; Carneiro CM; C Bandeira L; Faria G; Gonçalves RV; Novaes RD; Caldas S; Caldas IS
    Int Immunopharmacol; 2024 Feb; 128():111467. PubMed ID: 38211479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S. mansoni-T. cruzi co-infection modulates arginase-1/iNOS expression, liver and heart disease in mice.
    Rodrigues JPF; Caldas IS; Gonçalves RV; Almeida LA; Souza RLM; Novaes RD
    Nitric Oxide; 2017 Jun; 66():43-52. PubMed ID: 28268114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-nitrobenzoylcoumarin potentiates the antiparasitic, anti-inflammatory and cardioprotective effects of benznidazole in a murine model of acute Trypanosoma cruzi infection.
    Vilas-Boas DF; Oliveira RRG; Gonçalves-Santos E; Silva LS; Diniz LF; Mazzeti AL; Brancaglion GA; Carvalho DT; Caldas S; Novaes RD; Caldas IS
    Acta Trop; 2022 Apr; 228():106314. PubMed ID: 35038424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could phenothiazine-benznidazole combined chemotherapy be effective in controlling heart parasitism and acute infectious myocarditis?
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Pharmacol Res; 2020 Aug; 158():104907. PubMed ID: 32416214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could pre-infection exercise training improve the efficacy of specific antiparasitic chemotherapy for Chagas disease?
    Santos EG; Gonçalves RV; Souza-Silva TG; Maldonado IRSC; Santos EC; Talvani A; Natali AJ; Novaes RD
    Parasitology; 2019 Nov; 146(13):1655-1664. PubMed ID: 31362797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection.
    Strauss M; Lo Presti MS; Bazán PC; Baez A; Fauro R; Esteves B; Sanchez Negrete O; Cremonezzi D; Paglini-Oliva PA; Rivarola HW
    Parasitol Int; 2013 Jun; 62(3):293-9. PubMed ID: 23500720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strongyloides venezuelensis-infection alters the profile of cytokines and liver inflammation in mice co-infected with Schistosoma mansoni.
    de Rezende MC; Moreira JMP; Fernandes LLM; Rodrigues VF; Negrão-Corrêa D
    Cytokine; 2020 Mar; 127():154931. PubMed ID: 31783260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi
    Pandey RP; Nascimento MS; Franco CH; Bortoluci K; Silva MN; Zingales B; Gibaldi D; Castaño Barrios L; Lannes-Vieira J; Cariste LM; Vasconcelos JR; Moraes CB; Freitas-Junior LH; Kalil J; Alcântara L; Cunha-Neto E
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0028422. PubMed ID: 36314800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic Antagonist Suramin Aggravates Myocarditis and Increases Mortality by Enhancing Parasitism, Inflammation, and Reactive Tissue Damage in
    Novaes RD; Santos EC; Cupertino MC; Bastos DSS; Mendonça AAS; Marques-da-Silva EA; Cardoso SA; Fietto JLR; Oliveira LL
    Oxid Med Cell Longev; 2018; 2018():7385639. PubMed ID: 30364017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IL-33/ST2 pathway is not essential to Th2 stimulation but is key for modulation and survival during chronic infection with Schistosoma mansoni in mice.
    Maggi L; Rocha IC; Camelo GMA; Fernandes VR; Negrão-Corrêa D
    Cytokine; 2021 Feb; 138():155390. PubMed ID: 33341001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, cardiomyocytes premature senescence and contractile dysfunction in in vitro and in vivo experimental models of Chagas disease.
    Nogueira SS; Souza MA; Santos EC; Caldas IS; Gonçalves RV; Novaes RD
    Acta Trop; 2023 Aug; 244():106950. PubMed ID: 37211152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant exercise training attenuates the cardioprotective effects of pharmacological therapy in a murine model of acute infectious myocarditis.
    Mendonça AAS; Gonçalves RV; Souza-Silva TG; Maldonado IRSC; Talvani A; Natali AJ; Novaes RD
    Life Sci; 2019 Aug; 230():141-149. PubMed ID: 31129142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii.
    Lozano E; Strauss M; Spina R; Cifuente D; Tonn C; Rivarola HW; Sosa MA
    Parasitol Int; 2016 Feb; 65(1):23-26. PubMed ID: 26341064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol.
    Cafferata ML; Toscani MA; Althabe F; Belizán JM; Bergel E; Berrueta M; Capparelli EV; Ciganda Á; Danesi E; Dumonteil E; Gibbons L; Gulayin PE; Herrera C; Momper JD; Rossi S; Shaffer JG; Schijman AG; Sosa-Estani S; Stella CB; Klein K; Buekens P
    Reprod Health; 2020 Aug; 17(1):128. PubMed ID: 32831069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic rapamycin pretreatment modulates arginase/inducible nitric oxide synthase balance attenuating aging-dependent susceptibility to Trypanosoma cruzi infection and acute myocarditis.
    Pereira-Santos M; Gonçalves-Santos E; Souza MA; Caldas IS; Lima GDA; Gonçalves RV; Novaes RD
    Exp Gerontol; 2022 Mar; 159():111676. PubMed ID: 34968674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy.
    Gonçalves-Santos E; Vilas-Boas DF; Diniz LF; Veloso MP; Mazzeti AL; Rodrigues MR; Oliveira CM; Fernandes VHC; Novaes RD; Chagas-Paula DA; Caldas IS
    Int Immunopharmacol; 2019 Dec; 77():105961. PubMed ID: 31685438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.